Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Shares Issued (2019 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Shares Issued for 8 consecutive years, with $1000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued rose 100.0% year-over-year to $1000.0, compared with a TTM value of $249000.0 through Sep 2025, up 100.1%, and an annual FY2024 reading of $7.5 million, up 1003.81% over the prior year.
  • Shares Issued was $1000.0 for Q3 2025 at Bicycle Therapeutics, roughly flat from $1000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $543.2 million in Q2 2024 and bottomed at -$537.8 million in Q3 2024.
  • Average Shares Issued over 5 years is $15.8 million, with a median of $195000.0 recorded in 2022.
  • The sharpest move saw Shares Issued soared 2938650.0% in 2021, then crashed 134507.03% in 2023.
  • Year by year, Shares Issued stood at $286.1 million in 2021, then crashed by 99.94% to $185000.0 in 2022, then plummeted by 134507.03% to -$248.7 million in 2023, then surged by 100.1% to $245000.0 in 2024, then tumbled by 99.59% to $1000.0 in 2025.
  • Business Quant data shows Shares Issued for BCYC at $1000.0 in Q3 2025, $1000.0 in Q2 2025, and $2000.0 in Q1 2025.